bladder cancer study for cisplatin-ineligible patients after progression on pd-1 or pd-l1 therapy
Published 4 years ago • 54 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
3:05
bladder cancer clinical trial for cisplatin-ineligible patients
-
4:50
cisplatin-ineligible treatment options for advanced bladder cancer - bladder cancer video library
-
4:26
the evolution of first line therapy in cisplatin-ineligible patients - bladder cancer video library
-
3:45
treatment options for cisplatin-ineligible patients with advanced bladder cancer
-
1:23
how effective is pembrolizumab in cisplatin-ineligible bladder cancer? results from keynote-052
-
13:25
treatment considerations for patients with cisplatin-ineligible bladder cancer
-
4:35
adapt-bladder cancer research study
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:45
case 2: i/o therapy for cisplatin-ineligible bladder cancer
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
4:39
bladder cancer genomic research study
-
8:24
case 2: combination therapy for cis-ineligible bladder cancer
-
6:58
promising treatment options for advanced bladder cancer
-
31:06
bladder cancer | 2022 oneoncology conference
-
1:08
case 2: cisplatin-ineligible metastatic bladder cancer
-
1:03
dr. inman discusses the biology of bladder cancer